Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Airbnb
TI
TickerTickle
Community Contributor
Airbnb (ABNB): Still one of the most interesting bets in travel
Key insights Airbnb is changing from a travel-only app to a full lifestyle platform (stays, rentals, experiences) International markets are growing faster than the US, which is slowing down Product experience is improving a lot, with AI making search and booking easier Regulations are becoming a big risk, especially in Europe where listings are getting removed The way people move around the world has changed. It’s not only about holidays anymore.
View narrative
US$163.75
FV
27.8% undervalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
4
users have liked this narrative
0
users have commented on this narrative
11
users have followed this narrative
New
narrative
ING Groep
PI
PittTheYounger
Community Contributor
ING leads the pack when it comes to pivoting towards non-lending income
ING, of course, is a bank; and banks don't like falling interest rates, right? For the dominant stream of income is their core business model, i.e. borrowing short-term and lending long-term, reaping the difference in interest rates in the process.
View narrative
€27.92
FV
25.2% undervalued
intrinsic discount
9.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
New
narrative
Coles Group
RO
Robbo
Community Contributor
Coles (ASX: COL): Safe, Steady, and Surprisingly Cheap
The supermarket chain Coles is the kind of “boring” business that may have been overlooked as an investment opportunity. Although it was divested from Wesfarmers in 2018, Coles’ heritage traces back to 1914 — giving it over 110 years of history.
View narrative
AU$22.00
FV
5.0% undervalued
intrinsic discount
8.72%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Welspun
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Global Infrastructure Cycles Will Erode US, India And Saudi Capacity
Key Takeaways Future growth and profitability are exposed to risks from project delays, global policy shifts, and unproven demand assumptions for infrastructure and energy. Expanding capacity and reliance on local manufacturing may not offset vulnerabilities to competitive threats, protectionism, or adverse regulatory and cost pressures.
View narrative
₹1.09k
FV
19.4% undervalued
intrinsic discount
24.30%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
8 days ago
author updated this narrative
Sotera Health
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Sterigenics And Nelson Labs Will Capture New Opportunities
Key Takeaways Sotera Health’s strategic capital deployment focuses on reducing capital expenditure and improving leverage ratios to boost free cash flow and earnings. Growth in the sterilization service market and regulatory expertise are set to positively impact revenue and margins in high-value segments.
View narrative
US$15.75
FV
10.7% undervalued
intrinsic discount
6.39%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
Updated
narrative
Nova
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Advanced Packaging Demand And Metrion Adoption Will Support Future Success
Key Takeaways Nova's innovative materials metrology solutions and strategic acquisitions are key drivers of revenue growth and expanded market presence. Strong gross margins and increased tool sales from new customer acquisitions support sustained net margin expansion.
View narrative
US$290.00
FV
6.1% undervalued
intrinsic discount
11.54%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
16
users have followed this narrative
Updated
narrative
Affiliated Managers Group
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
Persistent Global Demand And Private Markets Will Unlock Value
Key Takeaways Surging demand for alternative and tax-efficient strategies is driving significant revenue and margin growth via higher management and performance fees from specialized affiliates. Ongoing affiliate investments and disciplined capital allocation support expanding shareholder value, margin improvement, and resilience against fee compression in commoditized segments.
View narrative
US$234.29
FV
8.6% undervalued
intrinsic discount
2.73%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
6 days ago
author updated this narrative
Eris Lifesciences
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts
India's Shift To Branded Generics Will Expand Chronic Therapy Markets
Key Takeaways Eris is poised for revenue and margin expansion due to its chronic therapy pipeline, branded generics focus, and strategic capacity additions. Market growth is supported by deeper doctor engagement, tier 2/3 city expansion, and execution of international export strategies.
View narrative
₹1.85k
FV
9.3% undervalued
intrinsic discount
15.97%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
Updated
narrative
Oatly Group
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Expanding Global Markets Will Capture Evolving Plant-Based Demand
Key Takeaways Broad product innovation and targeted launches are capturing demand from younger, health-conscious consumers, supporting rapid global expansion and brand strength. Operational efficiencies, local production, and strategic review in China are improving margins and positioning the company for sustained profitability and market leadership.
View narrative
US$19.37
FV
15.1% undervalued
intrinsic discount
4.63%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
23
users have followed this narrative
5 days ago
author updated this narrative
Mersen
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Renewable Energy And Electrification Will Expand Global Markets
Key Takeaways Growth in renewables, electrification, and power electronics is expected to drive strong revenue and margin expansion as market conditions improve and new contracts ramp up. Strategic investments in advanced materials, global expansion, and operational efficiency should stabilize revenue streams, enhance pricing power, and support long-term profitability.
View narrative
€28.37
FV
10.8% undervalued
intrinsic discount
3.80%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
26
users have followed this narrative
5 days ago
author updated this narrative
Sumitomo Chemical India
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Meshi, Ormie, And Portion Launches Will Propel Revenue Growth And Expand Exports
Key Takeaways Product launches and strategic campaigns are bolstering sales growth and market presence, positioning the company for future revenue expansion and improved margins. Strengthening export markets and increased agrochemical demand are expected to support revenue and earnings growth, aided by higher production capabilities and favorable agricultural conditions.
View narrative
₹618.50
FV
3.9% undervalued
intrinsic discount
11.77%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
8
users have followed this narrative
Updated
narrative
LyondellBasell Industries
AN
AnalystConsensusTarget
Consensus Narrative from 18 Analysts
Circular Recycling And Renewable Feedstock Investments Will Redefine Global Chemicals
Key Takeaways Strategic focus on recycling, sustainable plastics, and portfolio shifts toward low-cost regions positions the company for improved margins, resilient earnings, and revenue growth. Leadership in proprietary recycling technology and industry partnerships strengthens product differentiation, pricing power, and long-term returns amid rising sustainability demands.
View narrative
US$62.11
FV
22.2% undervalued
intrinsic discount
-8.73%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
62
users have followed this narrative
6 days ago
author updated this narrative
Value any company in seconds
Popular companies